IPSEN – Buy-back programme – Art 5 of MAR – Week 49- 2025
| Aggregated presentation by day and by market
Statement of transactions in own shares from December 1st to December 05th 2025 |
||||||
| Name of the issue | Identity code of the issuer (Legal Entity Identifier) |
Day of the transaction | Identity code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 200 | 124,05000 | AQEU |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 831 | 123,81540 | CEUX |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 100 | 124,40000 | TQEX |
| IPSEN | 549300M6SGDPB4Z94P11 | 01/12/2025 | FR0010259150 | 1897 | 124,16958 | XPAR |
| 3028 | 124,07209 | |||||
Attachment
Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 48 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 47 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 46 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 45 – 2025
Ipsen – October 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 44 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 43 – 2025
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
IPSEN – Buy-back programme – Art 5 of MAR – Week 42 – 2025